Search - tctmd.com

Displaying 561 - 580 of 706

Sort: Relevancy | Date

News Daily News

Revascularization After CTA Confers Mortality Benefit in Stable Patients at High Risk

L.A. McKeown

October 15, 2012

News Daily News

Almost 1 in 10 STEMIs Caused by Stent Thrombosis

October 12, 2012

News Daily News

Apixaban Matches Bleeding Risk of Aspirin in A-fib Patients

L.A. McKeown

October 10, 2012

News Daily News

Drug-eluting Balloons Show Positive Results in Treating In-stent Restenosis

Jason Kahn

October 05, 2012

News Daily News

Apixaban Surpasses Warfarin At All Risk Levels in A-Fib Patients

Caitlin E. Cox

October 04, 2012

News Daily News

Two Decades After MI, Women Show Better Survival Than Men

Yael L. Maxwell

October 03, 2012

News Daily News

Frailty Index Best at Predicting Functional Decline After TAVR

Yael L. Maxwell

September 28, 2012

News Daily News

Paper Raises Doubts About Need for Further Testing After Resolved Chest Pain

L.A. McKeown

September 24, 2012

News Daily News

Many Factors Contributed Toward Periprocedural Stroke in SAMMPRIS Trial

September 21, 2012

News Daily News

Early Invasive Strategy in NSTEMI Patients Improves Survival

September 18, 2012

News Daily News

SCAAR Data Support Obesity Paradox: Overweight ACS Patients Show Lower Mortality

Jason Kahn

September 11, 2012

News Daily News

Meta-analysis Takes an Indirect Look at Differences Among Novel Anticoagulants

September 11, 2012

News Conference News ESC 2012

WOEST: Clopidogrel Alone Works Best for PCI Patients on Oral Anticoagulants

Yael L. Maxwell

August 28, 2012

News Conference News ESC 2012

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

August 26, 2012

News Daily News

Cerebral Embolization During TAVR Comparable Across Access Routes, Devices

August 24, 2012

News Daily News

COMFORTABLE AMI Published: Biodegradable-Polymer DES Bests BMS in STEMI

Yael L. Maxwell

August 23, 2012

News Daily News

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

L.A. McKeown

August 20, 2012

News Daily News

Meta-analysis: DES Acceptable but Not Trouble-Free for Left Main Disease

Caitlin E. Cox

August 16, 2012

News Daily News

No Safe Window for Triple Antithrombotic Therapy in High-Risk A-fib Patients

August 14, 2012

News Daily News

PARTNER Analysis: Vascular Complications Common in Transfemoral TAVR

Jason Kahn

August 14, 2012

Advertisement

Revascularization After CTA Confers Mortality Benefit in Stable Patients at High Risk

Almost 1 in 10 STEMIs Caused by Stent Thrombosis

Apixaban Matches Bleeding Risk of Aspirin in A-fib Patients

Drug-eluting Balloons Show Positive Results in Treating In-stent Restenosis

Apixaban Surpasses Warfarin At All Risk Levels in A-Fib Patients

Two Decades After MI, Women Show Better Survival Than Men

Frailty Index Best at Predicting Functional Decline After TAVR

Paper Raises Doubts About Need for Further Testing After Resolved Chest Pain

Many Factors Contributed Toward Periprocedural Stroke in SAMMPRIS Trial

Early Invasive Strategy in NSTEMI Patients Improves Survival

SCAAR Data Support Obesity Paradox: Overweight ACS Patients Show Lower Mortality

Meta-analysis Takes an Indirect Look at Differences Among Novel Anticoagulants

WOEST: Clopidogrel Alone Works Best for PCI Patients on Oral Anticoagulants

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

Cerebral Embolization During TAVR Comparable Across Access Routes, Devices

COMFORTABLE AMI Published: Biodegradable-Polymer DES Bests BMS in STEMI

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

Meta-analysis: DES Acceptable but Not Trouble-Free for Left Main Disease

No Safe Window for Triple Antithrombotic Therapy in High-Risk A-fib Patients

PARTNER Analysis: Vascular Complications Common in Transfemoral TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content